General Statement of Disclosure:
OTHER FINANCIAL BENEFIT: Amgen Inc.(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), hls therapeutics(SIGNIFICANT), Novartis Corporation(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), Janssen Pharmaceuticals, Inc(SIGNIFICANT)